InsidersTradesSigma
Follow the 제넥신 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 제넥신 has recorded 1 reports. Market capitalisation: €109.8bn. The latest transaction was disclosed on 11 March 2026 (Other). Among the most active insiders: 제넥신. The full history is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Genexine is a biotechnology company focused on developing innovative drugs for the treatment of autoimmune diseases and cancers. It is listed on the XKRX market.